MEIP — MEI Pharma Cashflow Statement
0.000.00%
Last trade - 00:00
- $20.12m
- -$39.36m
- $48.82m
- 58
- 100
- 21
- 62
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K/A | 10-K/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -16.8 | -47.2 | -41.3 | -54.5 | -31.8 |
Depreciation | |||||
Non-Cash Items | -21.1 | 29.9 | -7.88 | -11.5 | 3.92 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 8.39 | 51.4 | 16.9 | 16.9 | -24.9 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -29.4 | 34.3 | -32 | -48.7 | -52.5 |
Capital Expenditures | -0.217 | -0.894 | -0.708 | -0.479 | -0.035 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 24.5 | -105 | 25.4 | 7.37 | 53.7 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 24.3 | -106 | 24.7 | 6.89 | 53.7 |
Financing Cash Flow Items | -0.324 | 5.27 | — | -3.85 | -0.04 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 1.39 | 74.8 | 3.47 | 49.1 | -0.04 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3.72 | 2.74 | -3.79 | 7.2 | 1.17 |